CP-866087 is a selective mu-opioid receptor antagonist. References: Orri M, Abraham L, Giraldi A. A phase 2a multicenter, double-blind, placebo-controlled, crossover trial to investigate the efficacy, safety, and toleration of CP-866,087 (a high-affinity mu-opioid receptor antagonist) in premenopausal women diagnosed with female sexual arousal disorder (FSAD). J Sex Med. 2013 Oct;10(10):2484-96. doi: 10.1111/jsm.12071. Epub 2013 Jan 24. PubMed PMID: 23347610.

纯度：≥98%

CAS：519052-02-9